329 related articles for article (PubMed ID: 16019723)
1. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
Karasik A
Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
Zeymer U
Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
[TBL] [Abstract][Full Text] [Related]
3. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.
Delorme S; Chiasson JL
Curr Opin Pharmacol; 2005 Apr; 5(2):184-9. PubMed ID: 15780829
[TBL] [Abstract][Full Text] [Related]
4. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
Sanusi H
Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
[TBL] [Abstract][Full Text] [Related]
5. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events.
Gao W; Qiao Q; Tuomilehto J
Clin Lab; 2004; 50(9-10):609-15. PubMed ID: 15481637
[TBL] [Abstract][Full Text] [Related]
6. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.
Ceriello A; Davidson J; Hanefeld M; Leiter L; Monnier L; Owens D; Tajima N; Tuomilehto J;
Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):453-6. PubMed ID: 16934443
[TBL] [Abstract][Full Text] [Related]
7. Glucose and cardiovascular risk.
Fuchs M; Hoekstra JB; Mudde AH
Neth J Med; 2002 Jun; 60(5):192-9. PubMed ID: 12365474
[TBL] [Abstract][Full Text] [Related]
8. Reflecting on type 2 diabetes prevention: more questions than answers!
Rosenstock J
Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
[TBL] [Abstract][Full Text] [Related]
9. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?
Yosefy C
Acta Diabetol; 2003 Dec; 40 Suppl 2():S380-8. PubMed ID: 14704873
[TBL] [Abstract][Full Text] [Related]
11. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
[TBL] [Abstract][Full Text] [Related]
12. Postprandial glucose regulation and diabetic complications.
Ceriello A; Hanefeld M; Leiter L; Monnier L; Moses A; Owens D; Tajima N; Tuomilehto J
Arch Intern Med; 2004 Oct; 164(19):2090-5. PubMed ID: 15505121
[TBL] [Abstract][Full Text] [Related]
13. Inadequacies of absolute threshold levels for diagnosing prediabetes.
Bergman M
Diabetes Metab Res Rev; 2010 Jan; 26(1):3-6. PubMed ID: 20101658
[TBL] [Abstract][Full Text] [Related]
14. Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice.
Boutati EI; Raptis SA
Diabetes Metab Res Rev; 2004; 20 Suppl 2():S13-23. PubMed ID: 15551342
[TBL] [Abstract][Full Text] [Related]
15. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.
Deedwania PC; Fonseca VA
Am J Med; 2005 Sep; 118(9):939-47. PubMed ID: 16164876
[TBL] [Abstract][Full Text] [Related]
16. From hyperglycemia to the risk of cardiovascular disease.
Leiter LA
Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose tolerance--fact or fiction.
Alberti KG
Diabet Med; 1996; 13(3 Suppl 2):S6-8. PubMed ID: 8689861
[TBL] [Abstract][Full Text] [Related]
18. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.
Bonora E; Muggeo M
Diabetologia; 2001 Dec; 44(12):2107-14. PubMed ID: 11793012
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
Petersen JL; McGuire DK
Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study.
Boas Soja AM; Zwisler AD; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):784-90. PubMed ID: 17001219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
